Biotech and Pharma

Pfizer said it would buy a clinical stage biopharma company for up to $7 billion, as it eyes the lucrative weight-loss drug market currently dominated by Eli Lilly and Novo Nordisk.

In a study with people with Type 2 diabetes and cardiovascular disease, the drug Ozempic was shown to reduce the risk of heart attack, stroke and death by 23% compared with an older drug.

Fed sees more downside risks for unemployment, Lilly and Novo Nordisk press ahead in weight-loss pill race, Walmart pushes to become a leader in agentic AI, and more news to start your day.

The data do continue to suggest it could be an important tool for patients with Type 2 diabetes.

The U.K.-based firm and other drugmakers are seeking to avoid tariffs on drugs imported into the U.S.

The weight loss drugmaker Novo Nordisk is trying to shore up its obesity pipeline with a potential alternative to its blockbuster Wegovy.

The FDA’s commissioner hasn’t mentioned any other drugmaker or retailer by name in his campaign against prescription drug ads.

Clinical trial results that showed the treatment reduced cardiovascular death, heart attack and stroke by 14% compared with placebo.

The 2024 presidential candidate served as CEO of Roivant Sciences until 2021.

Multiple outlets reported that Food and Drug Administration officials plan to make the case next week that the Covid-19 shots are linked to the deaths of 25 children.

The ads wouldn’t be banned outright, however.

Only 20% of analysts tracked by FactSet rate the stock at Buy.

The company is dealing with declining sales of its former cash-cow drug Humira.

For U.S. Big Pharma companies, vaccines have largely been an afterthought. But by 2030, they could be a quarter of Pfizer’s revenue.

The tests look for bits of altered DNA that cancer cells shed into the bloodstream. The screening technology holds hope of finding cancers early, when they might be cured.

Larry Ellison passes Elon Musk as world’s richest person, IPO mania returns, Labor Department investigates federal statistics gathering, and more news to start your day.

The effort falls well short of banning the ads outright, but could dent sales.

The weight-loss drugs company also slashed its profit guidance for the second time in six weeks.

Fed rate cuts and a positive earnings cycle could power a small-cap rally. The Calamos Timpani Small Cap Growth fund stands to benefit.

Some half a million cases of Lyme disease occur each year in the U.S., plus another 130,000 in Europe.

Apple shares slip as the tech company unveils several new iPhones at its annual launch event.

Last week, the SPDR S&P Biotech ETF surged 6%.

Novartis agrees to acquire Tourmaline Bio in an all-cash deal worth around $1.4 billion.

Echostar’s spectrum sale, StubHub revives IPO plans, Pfizer says new Covid shots are effective, and more news to start your day.

Ahead of a CDC committee meeting, Pfizer has released early data that it says show that its newest Covid-19 shot works. The committee, hand-picked by JFK Jr., includes many vaccine skeptics.